Hemab Therapeutics Holdings Inc. logo

Hemab Therapeutics (COAG) stock

COAG · Hemab Therapeutics Holdings Inc. · NASDAQ

Market cap
$1.84B
Shares out
46.7M

What is the latest news on COAG stock?

PRago
Hemab Therapeutics to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass. and COPENHAGEN, Denmark, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Hemab Therapeutics (NASDAQ:COAG), a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience, today announced that members of the Hemab Therapeutics management team will participate in the following upcoming investor conferences and host investor meetings. 2026 Jefferies Global Healthcare ConferenceFireside Chat: Tuesday, November 17, 2026, at 5:00 PM GMTLocation: London, United Kingdom 9th Annual Evercore Healthcare ConferenceFireside Chat: Tuesday, December 1, 2026, at 3:00 PM ETLocation: Coral Gables, FL A live w

All COAG news

When does Hemab Therapeutics report earnings?

Hemab Therapeutics last reported on Nov 10, 2026, the date it announced on Nov 3, 2026.

COAG earnings history

Who owns the most COAG stock?

Ra Capital Management, L.p. was the largest reported holder of COAG at the end of Q2 2026, with 7,808,627 shares worth $286.8 million. Next came Novo Holdings A/S ($153.6 million) and FMR LLC ($135.8 million). In all, 55 institutions reported $1.3 billion of COAG in their 13F filings.

All COAG fund holders

Latest news

8 items

COAG rankings

News · 26 weeks8+100%
2026-05-24: 02026-05-31: 02026-06-07: 02026-06-14: 02026-06-21: 02026-06-28: 02026-07-05: 02026-07-12: 02026-07-19: 02026-07-26: 02026-08-02: 02026-08-09: 02026-08-16: 02026-08-23: 02026-08-30: 02026-09-06: 02026-09-13: 02026-09-20: 02026-09-27: 02026-10-04: 02026-10-11: 02026-10-18: 02026-10-25: 02026-11-01: 32026-11-08: 52026-11-15: 0
2026-05-242026-11-15
Mix890d
  • Other3(38%)
  • Earnings2(25%)
  • SEC Filings2(25%)
  • 13D/G1(13%)
Activity · 52 weeks86 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Hemab Therapeutics Holdings Inc. (COAG) is a Biotechnology: Biological Products (No Diagnostic Substances) company listed on NASDAQ. In the last 30 days Quantisnow tracked 8 wire items for COAG, including 3 press releases and news items, 2 earnings updates and 2 SEC filings. The most recent was published Nov 11, 2026.

Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience. Hemab's mission is to discover, develop, and commercialize innovative therapies for the millions of patients worldwide suffering from serious bleeding and thrombotic diseases. Hemab is building a franchise of innovative therapeutics designed to address critical gaps in the treatment of coagulation disorders, including sutacimig (HMB-001), a bispecific antibody in clinical development for the prophylactic treatment of Glanzmann thrombasthenia and Factor VII deficiency, HMB-002, a monovalent antibody in clinical development for the prophylactic treatment of Von Willebrand Disease, and HMB-003, an antifibrinolytic targeting plasmin inhibition in clinical development for heavy menstrual bleeding.

COAG FAQ

6 questions
  • What does Hemab Therapeutics Holdings Inc. do?
    Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience. Hemab's mission is to discover, develop, and commercialize innovative therapies for the millions of patients worldwide suffering from serious bleeding and thrombotic diseases. Hemab is building a franchise of innovative therapeutics designed to address critical gaps in the treatment of coagulation disorders, including sutacimig (HMB-001), a bispecific antibody in clinical development for the...
  • Where does COAG stock trade?
    Hemab Therapeutics Holdings Inc. (COAG) is listed on NASDAQ.
  • What sector and industry is COAG in?
    Hemab Therapeutics Holdings Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.
  • When did Hemab Therapeutics Holdings Inc. go public?
    Hemab Therapeutics Holdings Inc. (COAG) completed its IPO in 2026.
  • What companies are similar to COAG?
    Notable peers in the same industry include SNY (Sanofi), PFE (Pfizer Inc.), NVO (Novo Nordisk A/S), TAK (Takeda Pharmaceutical Company Limited), VRTX (Vertex Pharmaceuticals Incorporated). Compare COAG side-by-side with any of them on Quantisnow.
  • How can I track COAG on Quantisnow?
    Quantisnow aggregates Hemab Therapeutics Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow COAG to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change